Why Bausch Health's Stock Is Trading Higher Today

Comments
Loading...

Bausch Health Companies BHC shares were trading higher on Tuesday, after the company announced a study arm evaluating 40 mg BID of Rifaximin SSD IR in combination with standard of care therapy met primary endpoint.

Bausch Health is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health, and neurology.

Bausch Health shares were trading up 4.26% at $15.90 on Tuesday. The stock has a 52-week high of $31.97 and a 52-week low of $11.15.

BHC Logo
BHCBausch Health Companies Inc
$5.50-3.00%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum15.66
Growth51.39
Quality-
Value41.65
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: